These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22699933)

  • 1. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma.
    Cheng Y; Xu J; Guo J; Jin Y; Wang X; Zhang Q; Liu L
    Clin Transl Oncol; 2013 May; 15(5):398-402. PubMed ID: 23054755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
    Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
    Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of natural IgG antibodies against ATP-binding cassette subfamily C member 3 in oral squamous cell carcinoma.
    Liu X; Huang Z; He Z; Meng Q; Wang X; Hu Y
    J Cancer Res Ther; 2019; 15(4):921-926. PubMed ID: 31436253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
    Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
    Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
    Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
    Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 8. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
    Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
    Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of circulating anti-CD25 antibodies in non-small cell lung cancer.
    Ye L; Li X; Sun S; Guan S; Wang M; Guan X; Lee KH; Wei J; Liu B
    Clin Transl Oncol; 2013 Aug; 15(8):633-7. PubMed ID: 23263913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma.
    Iizasa T; Fujisawa T; Saitoh Y; Hiroshima K; Ohwada H
    Cancer Immunol Immunother; 1998 Aug; 46(6):345-9. PubMed ID: 9756419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of NSCLC with scFv selected against IgM autoantibody.
    Pedchenko T; Mernaugh R; Parekh D; Li M; Massion PP
    PLoS One; 2013; 8(4):e60934. PubMed ID: 23585862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.
    Türeci O; Mack U; Luxemburger U; Heinen H; Krummenauer F; Sester M; Sester U; Sybrecht GW; Sahin U
    Cancer Lett; 2006 May; 236(1):64-71. PubMed ID: 15992994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
    Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
    Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B
    Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
    Jin Y; Guan S; Liu L; Sun S; Lee KH; Wei J
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e37-41. PubMed ID: 24811068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of Lung Cancer.
    Pan J; Yu L; Wu Q; Lin X; Liu S; Hu S; Rosa C; Eichinger D; Pino I; Zhu H; Qian J; Huang Y
    Mol Cell Proteomics; 2020 Mar; 19(3):490-500. PubMed ID: 31924693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
    Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
    Front Immunol; 2021; 12():728853. PubMed ID: 35140701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
    Liu S; Zhang X; Jiang Q; Liang T
    FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.